ChatchadaKaranesMD
Hematology • Duarte, CAHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Director, Cord blood transplant program
Dr. Karanes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111Fax+1 626-218-5446
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1976 - 1977- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1976
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1973 - 1975- Ascension Illinois/Saint FrancisInternship, Transitional Year, 1972 - 1973
Mahidol University Faculty of MedicineClass of 1971
Certifications & Licensure
IL State Medical License 1975 - Present
CA State Medical License 2004 - 2026
MN State Medical License 2001 - 2005
MI State Medical License 1979 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies Start of enrollment: 2006 Apr 01
- Adult Double Cord Blood Transplant Study Start of enrollment: 2007 Aug 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 422 citationsPhase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical...Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka, Steven M. Devine, J. L. Klein
Blood. 1998-10-01 - 39 citationsPosttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplantMonzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai
Blood Advances. 2021-06-22 - 294 citationsHigh-dose cytosine arabinoside therapy for refractory leukemiaRoger H. Herzig, Steven N. Wolff, Hillard M. Lazarus, Gordon L. Phillips, C. Karanes
Blood. 1983-08-01
Abstracts/Posters
- Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable RemissionsChatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary ResultsChatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...Chatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
